drugset / Trial / NCT07590193
A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants with type 2 diabetes mellitus (T2DM).
Timeline
- Start
- 2026-06-11
- Primary completion
- 2027-10-02
- Completion
- 2027-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMG 127 | Unknown | — | Subcutaneous |